Cutaneous endometriosis presented in a 43-year-old woman’s caesarian scar

In: Obstetrics & Gynecology International Journal · 2022 · vol. 13(6) , pp. 349–350 · doi:10.15406/ogij.2022.13.00675 · W4309933563
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-12

This case report describes a 43-year-old woman with cyclical pain in a cesarean scar, diagnosed via biopsy as cutaneous endometriosis, which improved with hormonal therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

This paper reports a case of secondary cutaneous endometriosis presenting as a red, tender papule and nodule in a 43-year-old woman’s cesarean scar, with symptoms recurring around ovulation and menstruation. The authors used a 3 mm punch biopsy with histopathology showing dermal endometrial glands with surrounding cytogenic stroma and blood, plus immunohistochemistry demonstrating ER-positive glands and CD-10+ stroma; ultrasound was used to exclude deep pelvic involvement. After referral to gynecology and placement of a hormonal spiral, the patient’s symptoms improved substantially and quality-of-life scores (DLQI) decreased from 5 to 0, though the authors note that recurrence risk exists if non-surgical treatment is discontinued. This paper is centrally about endometriosis — it documents secondary cutaneous endometriosis in a cesarean scar.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Cutaneous endometriosis is a rare skin condition with the presence of endometrial tissue in the skin. The condition most often affect fertile women and symptoms typically include cyclical tenderness, pain or itch of the tissue during ovulation and menstruation. We report a 43-year-old woman who presented with a red papule in a caesarian scar, with recurring tenderness and pain following ovulation and menstruation. Histopathological findings from a punch biopsy showed the presence of dermal endometrial glands surrounded by cytogenic stroma and blood. An immunohistochemical analysis further supported the diagnosis with ER-positive glands and CD-10+ stroma. The patient was referred to a gynecological ward where a hormonal spiral was inserted. This hormonal therapy reduced the patient’s clinical symptoms and improved her quality of life. Significance: Cutaneous endometriosis is an uncommon skin condition with the presence of ovarian tissue on the skin. It most often affects fertile women and cause skin tissue to becomes tender and painful during ovulation and menstruation. This can have a great impact on the patient’s quality of life. Treatment options include hormonal therapy and surgery.
Full text 8,698 characters · extracted from oa-pdf · 6 sections · click to expand

Introduction

Endometriosis is the presence of functional endometrial tissue with endometrial glands and stroma found outside the uterine cavity. The disorder is quite common with an estimated prevalence of 10- 15% of all fertile women. Typical symptoms include pelvic pain and impaired fertility.1 Most common sites involve the ovaries, uterosacral ligaments, ovarian fossa, pouch of Douglas and the bladder. 2 Cutaneous endometriosis is the presence of endometrial tissue in the skin and can be divided into primary and secondary cutaneous endometriosis. Primary cutaneous endometriosis refers to endometriosis developed spontaneously without any prior surgery. Its pathogenesis remains unclear. Theories include hematogenic or lymphatic spreading, seeding through anatomical and physiological structures such as the umbilicus and the differentiating of primitive pluripotent mesenchymal stem cells to endometrial tissue. Secondary cutaneous endometriosis is located in postoperative scars such as cesarean sections, hysterectomy or laparoscopy. The prevailing hypothesis stands that endometrial cells dislocate during surgery through the process of seeding.3 Cutaneous endometriosis is rare and comprise less than 1% of all reported cases of extra-uterine endometriosis. 4 The presentation is unspecific, a discolored nodular mass which can mimic hypertrophic or keloid scarring, dermatofibroma, dermatofibrosarcoma protuberans or malignant metastatic cancer from the umbilicus, a so-called Sister Mary Joseph’s nodule. The disorders rarity and ability to mimic other conditions presents diagnostic difficulties. The diagnosis is confirmed histopathologically. Treatment options include hormonal therapy and surgical excision with wide marginal.3 A few case studies report of malignant transformation into endometrial carcinoma. The prevalence as well as the pathophysiology of this is unknown. Genetic, immunological and hormonal factors have been implicated.5,6 Case report We present a 43-year-old woman with menarche at the age of nine. Since her menstrual debut she has suffered from menorrhagia, metrorrhagia and dysmenorrhea causing hospitalization on multiple occasions. A previous history of multiple ruptured ovarian cysts was recorded throughout her teenage years. Hormonal treatment with birth control pills was initiated but discontinued due to adverse side effects. She had difficulties becoming pregnant, and had two spontaneous abortions. With the help of IVF treatment, she became pregnant at the age of 29. She underwent an elective caesarian and delivered a healthy female offspring. A few days after surgery a red papule appeared on the right side of her abdominal scar. In the following years the papule and surrounding caesarian scar became noticeable tender during ovulation and menstruation. The tenderness and pain were reduced during the period she was breastfeeding and the symptoms reappeared when she stopped. She was referred to a dermatologist four years after her caesarian. At the first visit a red nodule, measuring 5x5mm, was noticed (Figure 1) (Figure 2). A 3mm punch biopsy (Figure 3) showed histopathological findings including dermal endometrial glands surrounding by cytogenic stroma and blood. An immunohistochemical analysis concluded that the glands were positive for ER, and the stroma CD- 10+. Figure 1 A red papule on an abdominal scar after elective caesarean. Obstet Gynecol Int J. 2022;13(6):349‒350. 349 ©2022 Kafi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially. Cutaneous endometriosis presented in a 43-year-old woman’s caesarian scar Volume 13 Issue 6 - 2022 Pegah Kafi,1 Carl Swartling2 1Kungsholmens Skin Clinic, Sweden 2Hyperhidros Clinic, Sweden Correspondence: Pegah Kafi, Kungsholmens Skin Clinic, Warfvinges Väg 35, 112 51 Stockholm, Sweden, Email Received: November 05, 2022 | Published: November 18, 2022

Abstract

Cutaneous endometriosis is a rare skin condition with the presence of endometrial tissue in the skin. The condition most often affect fertile women and symptoms typically include cyclical tenderness, pain or itch of the tissue during ovulation and menstruation. We report a 43-year-old woman who presented with a red papule in a caesarian scar, with recurring tenderness and pain following ovulation and menstruation. Histopathological findings from a punch biopsy showed the presence of dermal endometrial glands surrounded by cytogenic stroma and blood. An immunohistochemical analysis further supported the diagnosis with ER-positive glands and CD-10+ stroma. The patient was referred to a gynecological ward where a hormonal spiral was inserted. This hormonal therapy reduced the patient’s clinical symptoms and improved her quality of life. Significance: Cutaneous endometriosis is an uncommon skin condition with the presence of ovarian tissue on the skin. It most often affects fertile women and cause skin tissue to becomes tender and painful during ovulation and menstruation. This can have a great impact on the patient’s quality of life. Treatment options include hormonal therapy and surgery.

Keywords

cutaneous endometriosis, endometriosis, primary cutaneous endometriosis, secondary cutaneous endometriosis, hormone therapy Obstetrics & Gynecology International Journal Case Report Open Access Cutaneous endometriosis presented in a 43-year-old woman’s caesarian scar 350 Copyright: ©2022 Kafi et al. Citation: Kafi P , Swartling C. Cutaneous endometriosis presented in a 43-year-old woman’s caesarian scar. Obstet Gynecol Int J. 2022;13(6):349‒350. DOI: 10.15406/ogij.2022.13.00675 Figure 2 Dermatoscopic image of the red abdominal papule. Figure 3 Histopathological image of the 3mm punch biopsy. These histopathological findings are congruent with the diagnosis of cutaneous endometriosis. A noticeable pain relief was noticed after the punch biopsy was taken. At the first visit the patient scored DLQI of 5 and endometriosis assessment scale of EHP-30 of 97 out of 150. She was referred to a gynecological ward where ultrasound excluded deep endometriosis. A hormonal spiral was inserted. The hormonal therapy greatly reduced the patients’ clinical symptoms of dysmenorrhea and improved her quality of life with a reduction in DLQI to 0.

Discussion

Our case represents a fertile woman with a classical secondary cutaneous endometriosis in a cesarian scar. The symptoms of monthly pain and swelling became less noticeable after punch biopsy as well as hormonal therapy was initiated. Total surgical removal of the remaining tissue was not considered necessary. Further gynecological investigation with ultrasound excluded pelvic involvement. After initiating hormonal treatment, the patients’ symptoms were reduced and she had an improvement in quality of life, reflected by a decrease in DLQI. Referral to a gynecologist is highly recommended in order to evaluate the extend of endometriosis in the pelvic region, uterocutaneous fistulas and to assess treatment options such as surgical removal and hormonal therapy with gonadotropin-releasing hormone agonists or danazol. In some cases where surgery is needed preoperative hormonal treatment can be considered in order to minimize the lesion. The overall prognosis is considered favorable. There is a risk of recurrence once non-surgical treatment is discontinued.

Conclusion

Cutaneous endometriosis should be kept in mind as a differential diagnosis when a patient presents with cyclical painful papules, nodules and tumors. Acknowledgments None. Funding None. Conflicts of interest There are no conflicts of interest.

References

1. Tsamantioti ES, Mahdy H. Endometriosis. StatPearls; 2022. 2. Sharma A, Apostol R. Cutaneous endometriosis. Treasure Island (FL): StatPearls Publishing; 2022. 3. Raffi L, Suresh R, McCalmont TH, et al. Cutaneous endometriosis. Int J Womens Dermatol. 2019;5(5):384–386. 4. Victory R, Diamond MP, Johns DA. Villar’s nodule: a case report and systematic literature review of endometriosis externa of the umbilicus. J Minim Invasive Gynecol. 2007;14(1):23–32. 5. Nezhat F, Apostol R, Mahmoud M, et al. Malignant transformation of endometriosis and its clinical significance. Fertil Steril . 2014;102(2):342–344. 6. Nezhat FR, Apostol R, Nezhat C, et al. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am J Obstet Gynecol. 2015 Sep;213(3):262–267.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK